FindTrial
Sign In

The Study of Relationship Between Serum IL-32 and MAFLD Level in Hospitalized Patients with T2DM

The Study of Relationship Between Serum IL-32 and MAFLD Level in Hospitalized Patients with T2DM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048881
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

T2DM patients with MAFLD group:Nil
T2DM patients group:Nil

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Clinical data completly; 2. Meets the diagnostic criteria of T2DM in the Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020); 3. Aged 18 or above; 4. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Who were not performed the abdominal ultrasound; 2. The history of liver function damage caused by alcohol, drugs, viral hepatitis and other factors; 3. Acute or chronic liver and biliary diseases caused by other reasons; 4. Pregnant; 5. Patients suffering from mental diseases and malignant tumors.

Design outcomes

Primary

MeasureTime frame
IL-32;—

Countries

China

Contacts

Public ContactXiao Yuanyuan

Shanghai Sixth People's Hospital

forgetxyy@163.com+86 18017579949

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026